Literature DB >> 6431768

NMR of the normal and pathologic eye and orbit.

D F Sobel, C Mills, D Char, D Norman, M Brant-Zawadzki, L Kaufman, L Crooks.   

Abstract

Nuclear magnetic resonance (NMR) images of the eye and orbit were reviewed in a series of 100 normals and in four patients with orbital or ocular pathology. A rich retrobulbar fat content rendered the orbit well suited for NMR imaging. The lens, vitreous, optic nerve, and extraocular muscles were well visualized with spin-echo technique. However, NMR spatial resolution was inferior to that of high-resolution computed tomography (CT). NMR was comparable to CT in demonstrating choroidal melanoma and orbital pseudotumor. NMR exhibited a particular sensitivity in displaying tissue contrast for infiltrative orbital fat lesions with a relatively long T1. This initial experience suggests a promising role for NMR in orbital imaging.

Entities:  

Mesh:

Year:  1984        PMID: 6431768      PMCID: PMC8332056     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  5 in total

1.  High field resolution magnetic resonance imaging of malignant choroidal melanoma.

Authors:  L Lambrecht; R Allewaert; J J de Laey; H Verbraeken; J Bittoun; E van de Velde
Journal:  Int Ophthalmol       Date:  1988-02       Impact factor: 2.031

2.  Clinicopathologic correlation of orbital magnetic resonance imaging.

Authors:  M G Alper; L E Zimmerman; J L Sherman
Journal:  Trans Am Ophthalmol Soc       Date:  1986

Review 3.  Clinical applications of magnetic resonance imaging--current status.

Authors:  D Cammoun; W R Hendee; K A Davis
Journal:  West J Med       Date:  1985-12

Review 4.  Magnetic resonance imaging: an emerging technique for the diagnosis of ocular disorders.

Authors:  E V Smith; E S Gragoudas; N H Kolodny; D J D'Amico
Journal:  Int Ophthalmol       Date:  1990-03       Impact factor: 2.031

Review 5.  Clinical application of MRI in ophthalmology.

Authors:  Kelly A Townsend; Gadi Wollstein; Joel S Schuman
Journal:  NMR Biomed       Date:  2008-11       Impact factor: 4.044

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.